Notification

No new Notification messages

Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
dipna pharmachem limited stock

DIPNA PHARMACHEM LIMITED Share Price

- - (%)
- NSE: DPL

DIPNA PHARMACHEM LIMITED Share Price Update

As of the latest trading session, DIPNA PHARMACHEM LIMITED share price is currently at 8.26, which is down by -0.05 from its previous closing. Today, the stock has fluctuated between 8.21 and 8.31. Over the past year, DIPNA PHARMACHEM LIMITED has achieved a return of -57.62 %. In the last month alone, the return has been 15.41 %. Read More...

DIPNA PHARMACHEM LIMITED Performance

Day Range

Low8.21 High8.31
8.26

52 Week Range

Low 7.00 High 24.12
8.26

DIPNA PHARMACHEM LIMITED Share Price

543594

DPL

img img img img
No Data Available

Open Price

8.31

Prev. Close

8.31

Volume (Shares)

24000.00

Total traded value

1.98

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

DIPNA PHARMACHEM LIMITED Fundamentals


(Standalone)

Market Cap (Cr) 19.90
PE Ratio (TTM) 18.47
Book Value / Share 15.60
Beta 0.70
ROE 3.52%
EPS (TTM) 0.45
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.00

DIPNA PHARMACHEM LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 164.34
Operating Expense 162.93
Net Profit 1.09
Net Profit Margin (%) 0.66
Earnings Per Share (EPS) 0.90
EBITDA 3.44
Effective Tax Rate (%) 23.23
Particulars MAR 2023 (Values in Cr)
Revenue 99.93
Operating Expense 98.55
Net Profit 0.91
Net Profit Margin (%) 0.91
Earnings Per Share (EPS) 0.76
EBITDA 2.34
Effective Tax Rate (%) 34.05
Particulars MAR 2022 (Values in Cr)
Revenue 72.76
Operating Expense 71.19
Net Profit 1.17
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 333.39
EBITDA 2.21
Effective Tax Rate (%) 26.11
Particulars MAR 2021 (Values in Cr)
Revenue 31.00
Operating Expense 30.96
Net Profit 0.02
Net Profit Margin (%) 0.06
Earnings Per Share (EPS) 6.91
EBITDA 0.42
Effective Tax Rate (%) 50.00
Particulars MAR 2020 (Values in Cr)
Revenue 30.54
Operating Expense 30.49
Net Profit 0.06
Net Profit Margin (%) 0.19
Earnings Per Share (EPS) 16.86
EBITDA 0.46
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.60
ROE % 3.52
ROCE % 7.05
Total Debt to Total Equity 0.57
EBITDA Margin 2.10
Particulars MAR 2023 (Values in Cr)
Book Value / Share 20.35
ROE % 6.97
ROCE % 9.00
Total Debt to Total Equity 1.00
EBITDA Margin 2.36
Particulars MAR 2022 (Values in Cr)
Book Value / Share 496.73
ROE % 100.86
ROCE % 17.56
Total Debt to Total Equity 9.75
EBITDA Margin 3.01
Particulars MAR 2021 (Values in Cr)
Book Value / Share 163.34
ROE % 3.54
ROCE % 3.46
Total Debt to Total Equity 19.47
EBITDA Margin 1.32
Particulars MAR 2020 (Values in Cr)
Book Value / Share 156.43
ROE % 11.54
ROCE % 5.42
Total Debt to Total Equity 14.98
EBITDA Margin 1.51
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 13.87
Total Assets 132.90
Total Liabilities 132.90
Total Equity 37.51
Share Outstanding 24045250
Price to Book Ratio 0.60
Return on Assets (%) 0.81
Return on Capital (%) 1.91
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 5.69
Total Assets 77.55
Total Liabilities 77.55
Total Equity 24.35
Share Outstanding 11970000
Price to Book Ratio 0.62
Return on Assets (%) 1.17
Return on Capital (%) 2.26
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.20
Total Assets 36.22
Total Liabilities 36.22
Total Equity 1.73
Share Outstanding 35000
Price to Book Ratio 0.00
Return on Assets (%) 3.22
Return on Capital (%) 9.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 24.79
Total Liabilities 24.79
Total Equity 0.57
Share Outstanding 35000
Price to Book Ratio 0.00
Return on Assets (%) 0.09
Return on Capital (%) 0.19
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 18.44
Total Liabilities 18.44
Total Equity 0.54
Share Outstanding 35000
Price to Book Ratio 0.00
Return on Assets (%) 0.32
Return on Capital (%) 0.58
Particulars MAR 2024 (Values in Cr)
Net Income 1.41
Cash from Operations -5.08
Cash from Investing -0.01
Cash from Financing 13.61
Net change in Cash 8.18
Free Cash Flow -5.06
Particulars MAR 2023 (Values in Cr)
Net Income 1.38
Cash from Operations -20.50
Cash from Investing -0.01
Cash from Financing 26.47
Net change in Cash 5.48
Free Cash Flow -20.49
Particulars MAR 2022 (Values in Cr)
Net Income 1.57
Cash from Operations 3.21
Cash from Investing 0.00
Cash from Financing -2.84
Net change in Cash -0.04
Free Cash Flow 3.21
Particulars MAR 2021 (Values in Cr)
Net Income 0.05
Cash from Operations -2.41
Cash from Investing 0.00
Cash from Financing 2.50
Net change in Cash 0.07
Free Cash Flow -2.40
Particulars MAR 2020 (Values in Cr)
Net Income 0.05
Cash from Operations -3.11
Cash from Investing 0.00
Cash from Financing 3.17
Net change in Cash 0.06
Free Cash Flow -3.11
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.79 42.72 3.67 504.17 33.57 / 77.70
BLISS GVS PHARMA LTD 131.30 13.48 1.42 1378.20 77.65 / 148.95
CIPLA LTD 1628.10 29.58 4.92 131478.83 1132.00 / 1681.05
FERMENTA BIOTECH LIMITED 299.95 0.00 3.05 882.78 144.45 / 332.50
GLAXOSMITHKLINE PHARMA LT 2812.65 61.86 26.80 47647.99 1387.90 / 3087.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.79 99.68 12.51 504.17 33.57 / 77.70
AMRUTAJAN HEALTH LTD 816.95 55.46 8.18 2361.85 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6896.90 131.62 24.21 17242.25 4050.15 / 7550.00
BLISS GVS PHARMA LTD 131.30 14.12 1.39 1378.20 77.65 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 8.30
  • 26 Days 8.00
  • 10 Days 8.40
  • 50 Days 7.90
  • 12 Days 8.20
  • 100 Days 8.30
  • 20 Days 8.00
  • 200 Days 11.40
8.35
PIVOT
First Resistance 8.39
Second Resistance 8.48
Third Resistance 8.52
First Support 8.26
Second Support 8.22
Third Support 8.13
RSI 63.77
MACD 0.20
Commodity Channel Index (CCI) 43.99
ADX 40.69
Williams % R -53.99

Over 1 Month

down

15.41

Over 3 Months

down

3.61

Over 6 Months

down

-32.60

Over 1 Year

down

-57.62

Over 3 Years

down

0.00

Over 5 Years

down

0.00

DIPNA PHARMACHEM LIMITED Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

DIPNA PHARMACHEM LIMITED Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
90.02
Promoter Holdings
9.97
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Rathod Manoj Chhaganlal Huf Public Shareholding 3700000.0 15.39
Keyur Dipakkumar Shah Shareholding of Promoter and Promoter Group 2397000.0 9.97
Nirav M Kothari Public Shareholding 800000.0 3.33
Sunita Santosh Goenka Public Shareholding 518750.0 2.16
Anand Purshottamdas Laddha Public Shareholding 300000.0 1.25
Mr Bhaveshkumar Chandrakant Shah Public Shareholding 250000.0 1.04
Ms Jyotsanaben Chandrakant Shah Public Shareholding 250000.0 1.04
Dipna Keyur Shah Shareholding of Promoter and Promoter Group 2500.0 0.01
Dhara Nrupeshbhai Shah Shareholding of Promoter and Promoter Group 100.0 0.0
Chaitanya Chinubhai Nanavati Shareholding of Promoter and Promoter Group 100.0 0.0

DIPNA PHARMACHEM LIMITED

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About DIPNA PHARMACHEM LIMITED

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by DIPNA PHARMACHEM LIMITED

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Dipna Pharmachem Ltd?

Answer Field

The share price of Dipna Pharmachem Ltd for NSE is ₹ 0.00 and for BSE is ₹ 8.26.

What is the Market Cap of Dipna Pharmachem Ltd?

Answer Field

The market cap of Dipna Pharmachem Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 19.90 Cr. as of now.

What is the 52 Week High and Low of Dipna Pharmachem Ltd?

Answer Field

The 52 Week High and Low of Dipna Pharmachem Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 24.12 and ₹ 7.00.

How to Buy Dipna Pharmachem Ltd share?

Answer Field

You can trade in Dipna Pharmachem Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Dipna Pharmachem Ltd?

Answer Field

The 1 year returns on the stock has been -57.62%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text
loader